This work is licensed under the Creative Commons Attribution 4.0 International License.
Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003;48:209-231.BlackCPSystematic review of the biology and medical management of respiratory syncytial virus infection200348209231Search in Google Scholar
Greenough A. Role of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO. Pediatr Resp Rev. 2009;10:26-28.GreenoughARole of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO200910262810.1016/S1526-0542(09)70012-0Search in Google Scholar
Wiśniewska-Ligier A, Woźniakowska-Gęsicka T, Andrzejewski A, Wróblewska W. RSV infections remain dangerous. Article in Polish. Klin Pediatr 2008;16:42-46.Wiśniewska-LigierAWoźniakowska-GęsickaTAndrzejewskiAWróblewskaW.RSV infections remain dangerous2008164246Search in Google Scholar
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55.NairHNokesDJGessnerBDDheraniMMadhiSASingletonRJO’BrienKLRocaAWrightPFBruceNChandranATheodoratouESutantoASedyaningsihERNgamaMMunywokiPKKartasasmitaCSimõesEARudanIWeberMWCampbellHGlobal burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis201037515455510.1016/S0140-6736(10)60206-1Search in Google Scholar
Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, Borok G, Butylkova Y, Wegzyn C. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol. 2017;52:556-569.SteinRTBontLJZarHPolackFPParkCClaxtonABorokGButylkovaYWegzynCRespiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis20175255656910.1002/ppul.23570Search in Google Scholar
Rutkowska M, Helwich E, Borecka R, Gadzinowski J, Polak K, Czyżewska M, Kościesza A, Kornacka MK, Klimek M. Incidence of respiratory infections in children with bronchopulmonary dysplasia receiving prophylaxis with palivizumab. Article in Polish. Ped Pol. 2011;86:317-325.RutkowskaMHelwichEBoreckaRGadzinowskiJPolakKCzyżewskaMKościeszaAKornackaMKKlimekMIncidence of respiratory infections in children with bronchopulmonary dysplasia receiving prophylaxis with palivizumab20118631732510.1016/S0031-3939(11)70495-4Search in Google Scholar
Borecka R, Lauterbach R, Helwich E. Factors related to compliance with palivizumab prophylaxis for respiratory syncytial virus (RSV) infection - data from Poland. Dev Period Med. 2016;20:181-190.BoreckaRLauterbachRHelwichEFactors related to compliance with palivizumab prophylaxis for respiratory syncytial virus (RSV) infection - data from Poland201620181190Search in Google Scholar
Chan P, Li A, Paes B, Abraha H, Mitchell I, Lanctôt KL; CARESS investigators. Adherence to palivizumab for respiratory syncytial virus prevention in the Canadian Registry of Palivizumab. Pediatr Infect Dis J. 2015;34:e290-297.ChanPLiAPaesBAbrahaHMitchellILanctôtKL; CARESS investigators.Adherence to palivizumab for respiratory syncytial virus prevention in the Canadian Registry of Palivizumab201534e29029710.1097/INF.0000000000000922Search in Google Scholar
Sorrentino M, Powers T. Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab outcomes Study Group. Pediatr Infect Dis J. 2000;19:1068-1071.SorrentinoMPowersTEffectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab outcomes Study Group2000191068107110.1097/00006454-200011000-00007Search in Google Scholar
Frogel M, Nerwen C, Cohen A, VanVeldhuisen P, Harrington M, Boron M; Palivizumab Outcomes Registry Group. Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab outcomes Registry. J Perinatol. 2008;28:511-517.FrogelMNerwenCCohenAVanVeldhuisenPHarringtonMBoronM; Palivizumab Outcomes Registry Group.Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab outcomes Registry20082851151710.1038/jp.2008.28Search in Google Scholar
Simon A, Nowak H, Sterz R. Use of palivizumab in Germany: data from 2002-2007. Klin Padiatr. 2011;223:292-298.SimonANowakHSterzRUse of palivizumab in Germany: data from 2002-2007201122329229810.1055/s-0030-1270515Search in Google Scholar
Pignotti MS, Indolfi G, Donzelli G. Factors impacting compliance with palivizumab prophylaxis. Pediatr Infect Dis J. 2004;23:186-187.PignottiMSIndolfiGDonzelliGFactors impacting compliance with palivizumab prophylaxis20042318618710.1097/01.inf.0000110271.48794.a7Search in Google Scholar
Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143:S118-S126.SimoesEAEnvironmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease2003143S118S12610.1067/S0022-3476(03)00511-0Search in Google Scholar
Oh PI, Lanctôt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators. Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes. Pediatr Infect Dis J. 2002;21:512-518.OhPILanctôtKLYoonALeeDSPaesBASimmonsBSParisonDManziP; Composs Investigators.Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes20022151251810.1097/00006454-200206000-0000712182374Search in Google Scholar
Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung-function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319:1112-1117.MartinezFDMorganWJWrightALHolbergCJTaussigLMDiminished lung-function as a predisposing factor for wheezing respiratory illness in infants19883191112111710.1056/NEJM1988102731917023173442Search in Google Scholar
Giardino AP, Tran XG, Whitmire DA. Respiratory syncytial virus prevention outreach project. Tex Med 2009;105:e1.GiardinoAPTranXGWhitmireDARespiratory syncytial virus prevention outreach project2009105e1Search in Google Scholar
Bernard L, Lecomte B, Pereira B, Proux A, Boyer A, Sautou V. Impact of a targeted educational intervention on respiratory syncytial virus bronchiolitis prevention in full-term and preterm infants. Article in French. Arch Pediatr. 2015;22:146-153.BernardLLecomteBPereiraBProuxABoyerASautouVImpact of a targeted educational intervention on respiratory syncytial virus bronchiolitis prevention in full-term and preterm infants20152214615310.1016/j.arcped.2014.11.01525534557Search in Google Scholar
Lundeen K, Pfeiffenberger T, Jacobson Vann J, O’Brien T, Sampson C, Wegner S. Evaluation of a novel web-based prior approval application for palivizumab prophylaxis of respiratory syncytial virus in a state Medicaid program. J Manag Care Pharm. 2013;19:115-124.LundeenKPfeiffenbergerTJacobsonVann JO’BrienTSampsonCWegnerS.Evaluation of a novel web-based prior approval application for palivizumab prophylaxis of respiratory syncytial virus in a state Medicaid program20131911512410.18553/jmcp.2013.19.2.11523461427Search in Google Scholar